Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Wu, Chuanfeng
and
Dunbar, Cynthia E.
2011.
Stem cell gene therapy: the risks of insertional mutagenesis and approaches to minimize genotoxicity.
Frontiers of Medicine,
Vol. 5,
Issue. 4,
p.
356.
Humbert, Olivier
Davis, Luther
and
Maizels, Nancy
2012.
Targeted gene therapies: tools, applications, optimization.
Critical Reviews in Biochemistry and Molecular Biology,
Vol. 47,
Issue. 3,
p.
264.
Higgs, Douglas R
Engel, James Douglas
and
Stamatoyannopoulos, George
2012.
Thalassaemia.
The Lancet,
Vol. 379,
Issue. 9813,
p.
373.
Gambari, Roberto
2012.
Alternative options for DNA-based experimental therapy of β-thalassemia.
Expert Opinion on Biological Therapy,
Vol. 12,
Issue. 4,
p.
443.
Lai, Wing-Fu
2013.
Nucleic acid delivery: Roles in biogerontological interventions.
Ageing Research Reviews,
Vol. 12,
Issue. 1,
p.
310.
Yannaki, Evangelia
Karponi, Garyfalia
Zervou, Fani
Constantinou, Varnavas
Bouinta, Asimina
Tachynopoulou, Varvara
Kotta, Konstantina
Jonlin, Erica
Papayannopoulou, Thalia
Anagnostopoulos, Achilles
and
Stamatoyannopoulos, George
2013.
Hematopoietic Stem Cell Mobilization for Gene Therapy: Superior Mobilization by the Combination of Granulocyte–Colony Stimulating Factor Plus Plerixafor in Patients with β-Thalassemia Major.
Human Gene Therapy,
Vol. 24,
Issue. 10,
p.
852.
Groth, Amy C.
Liu, Mingdong
Wang, Hao
Lovelett, Emilie
Emery, David W.
and
Müller, Ferenc
2013.
Identification and Characterization of Enhancer-Blocking Insulators to Reduce Retroviral Vector Genotoxicity.
PLoS ONE,
Vol. 8,
Issue. 10,
p.
e76528.
Breda, Laura
Rivella, Stefano
Zuccato, Cristina
and
Gambari, Roberto
2013.
Combining gene therapy and fetal hemoglobin induction for treatment of β-thalassemia.
Expert Review of Hematology,
Vol. 6,
Issue. 3,
p.
255.
Finotti, Alessia
and
Gambari, Roberto
2014.
Recent trends for novel options in experimental biological therapy of β-thalassemia.
Expert Opinion on Biological Therapy,
Vol. 14,
Issue. 10,
p.
1443.
Vannocci, Tommaso
Kurata, Hitoshi
de la Fuente, Josu
Roberts, Irene A.
and
Porter, Andrew C. G.
2014.
Nuclease‐stimulated homologous recombination at the human β‐globin gene.
The Journal of Gene Medicine,
Vol. 16,
Issue. 1-2,
p.
1.
Yannaki, Evangelia
and
Karponi, Garyfalia
2014.
Current Status and Developments in Gene Therapy for Thalassemia and Sickle Cell Disease.
Thalassemia Reports,
Vol. 4,
Issue. 3,
p.
4876.
Boulad, Farid
Wang, Xiuyan
Qu, Jinrong
Taylor, Clare
Ferro, Leda
Karponi, Garyfalia
Bartido, Shirley
Giardina, Patricia
Heller, Glenn
Prockop, Susan E.
Maggio, Aurelio
Sadelain, Michel
and
Rivière, Isabelle
2014.
Safe mobilization of CD34+ cells in adults with β-thalassemia and validation of effective globin gene transfer for clinical investigation.
Blood,
Vol. 123,
Issue. 10,
p.
1483.
Karponi, Garyfalia
Psatha, Nikoletta
Lederer, Carsten Werner
Adair, Jennifer Eileen
Zervou, Fani
Zogas, Nikolaos
Kleanthous, Marina
Tsatalas, Constantinos
Anagnostopoulos, Achilles
Sadelain, Michel
Rivière, Isabelle
Stamatoyannopoulos, George
and
Yannaki, Evangelia
2015.
Plerixafor+G-CSF–mobilized CD34+ cells represent an optimal graft source for thalassemia gene therapy.
Blood,
Vol. 126,
Issue. 5,
p.
616.
Psatha, Nikoletta
Karponi, Garyfalia
and
Yannaki, Evangelia
2016.
Optimizing autologous cell grafts to improve stem cell gene therapy.
Experimental Hematology,
Vol. 44,
Issue. 7,
p.
528.
Constantinou, Varnavas C.
Bouinta, Asimina
Karponi, Garyfalia
Zervou, Fani
Papayanni, Penelope‐Georgia
Stamatoyannopoulos, George
Anagnostopoulos, Achilles
and
Yannaki, Evangelia
2017.
Poor stem cell harvest may not always be related to poor mobilization: lessons gained from a mobilization study in patients with β‐thalassemia major.
Transfusion,
Vol. 57,
Issue. 4,
p.
1031.
Wang, Yi
and
Lai, Wing-Fu
2020.
Systemic Delivery Technologies in Anti-Aging Medicine: Methods and Applications.
Vol. 13,
Issue. ,
p.
3.
Grech, Laura
Borg, Karen
and
Borg, Joseph
2022.
Novel therapies in β‐thalassaemia.
British Journal of Clinical Pharmacology,
Vol. 88,
Issue. 6,
p.
2509.